histidine has been researched along with sorafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Liu, T; Liu, Y; Wang, L; Yao, Y; Yu, D; Zhang, L; Zhang, N | 1 |
| Abe, S; Fujisawa, K; Furutani-Seiki, M; Goto, R; Inoue, R; Kamimura, K; Koyama, N; Nagoya, T; Nishina, H; Nozawa, Y; Ogawa, K; Sakai, N; Sakaida, I; Sakamaki, A; Shinagawa-Kobayashi, Y; Sugitani, S; Terai, S; Yanagi, M; Yokoo, T | 1 |
2 other study(ies) available for histidine and sorafenib
| Article | Year |
|---|---|
Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Contrast Media; Drug Carriers; Hep G2 Cells; Histidine; Humans; Hydrogen-Ion Concentration; Lactic Acid; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Niacinamide; Particle Size; Phenylurea Compounds; Polyesters; Polyethylene Glycols; Polymers; Radiography; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Transplantation, Heterologous | 2014 |
Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model.
Topics: Animals; Antineoplastic Agents; Blood Flow Velocity; Blood Vessels; Carcinoma, Hepatocellular; Histidine; Humans; Liver Neoplasms; Niacinamide; Oryzias; Phenylurea Compounds; Sorafenib | 2018 |